Adaptive Biotechnologies Corporation ADPT
29.43
(0.14)
(0.47%)
as of 25 Sep
- Market cap
- $4.7B
- P/E
- 0.0×
Follow ADPT
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(37.22%) | (27.84%) | (23.97%) | (38.68%) | |
| (15.18%) | (11.31%) | (9.77%) | (11.23%) | ||
ROIC |
0.00% | 0.00% | (494.38%) | (16.57%) | |
Return on Tangible Assets |
(33.80%) | (24.35%) | (21.09%) | (17.62%) | |
Average Days of Receivables |
64.73 | 66.37 | 59.70 | 58.66 | |
Free Cash Flow per Share |
(0.41) | (0.32) | (0.19) | (0.15) | |
Free Cash Flow |
(62.93) | (48.94) | (29.53) | (24.03) | |
Capital Expenditures |
(2.40) | (2.96) | (2.50) | (3.02) | |
Piotroski F-Score |
4.00 | 5.00 | 5.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
(14.52%) | (10.17%) | (6.11%) | (2.53%) | |
Accounts Receivable Turnover |
5.90 | 6.01 | 6.43 | 6.57 | |
Accounts Payable Turnover |
8.08 | 10.39 | 9.15 | 12.39 | |
Inventory Turnover |
6.50 | 7.82 | 7.35 | 7.96 | |
Average Days of Payables |
52.65 | 33.08 | 48.02 | 25.42 | |
Days of Inventory on Hand |
50.93 | 50.23 | 55.96 | 50.91 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
37.66% | 33.85% | 31.55% | 28.63% | |
Selling, General and Administrative Expense of Revenue |
64.44% | 60.39% | 58.95% | 58.55% | |
Share Based Compensation of Revenue |
20.41% | 18.59% | 17.35% | 15.91% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.76 | 0.77 | 0.54 | 0.33 | |
Depreciation/Fixed assets |
0.38 | 0.45 | 0.50 | 0.51 | |
Capex/Depreciation |
(0.17) | (0.19) | (0.16) | (0.20) | |
Revenue per Share |
1.66 | 1.83 | 1.90 | 1.93 | |
Operating CF per Share |
(0.40) | (0.30) | (0.17) | (0.13) | |
Capex per Share |
(0.02) | (0.02) | (0.02) | (0.02) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
(31.50%) | (21.48%) | (16.82%) | (20.73%) |
Columns are period end dates